{"id":"https://openalex.org/W2980665336","doi":null,"title":"Behandling av post-transplantasjonsdiabetes mellitus hos nyretransplanterte pasienter. Interimanalyse av sikkerhet og effekt ved bruk av empagliflozin (EMPA-RenalTx studien).","display_name":"Behandling av post-transplantasjonsdiabetes mellitus hos nyretransplanterte pasienter. Interimanalyse av sikkerhet og effekt ved bruk av empagliflozin (EMPA-RenalTx studien).","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2980665336","mag":"2980665336"},"language":"no","primary_location":{"id":"pmh:oai:www.duo.uio.no:10852/63520","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-66073","pdf_url":"http://urn.nb.no/URN:NBN:no-66073","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://urn.nb.no/URN:NBN:no-66073","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071619883","display_name":"Laavanyaah Rajakumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Laavanyaah Rajakumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5071619883"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.18209999799728394,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/post-transplant-diabetes-mellitus","display_name":"post-transplant diabetes mellitus","score":0.9079999923706055},{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.968999981880188},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/interim-analysis","display_name":"interim analysis","score":0.460999995470047},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.34299999475479126},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.578000009059906},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.4059999883174896},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.47200000286102295},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.5099999904632568},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.527999997138977},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.45100000500679016},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.938815176486969},{"id":"https://openalex.org/C2780652884","wikidata":"https://www.wikidata.org/wiki/Q5323607","display_name":"EMPA","level":3,"score":0.7508326172828674},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6226840615272522},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.24095997214317322},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.14322972297668457},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09467160701751709},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.05083611607551575},{"id":"https://openalex.org/C138411078","wikidata":"https://www.wikidata.org/wiki/Q911272","display_name":"Electron microprobe","level":2,"score":0.0},{"id":"https://openalex.org/C199289684","wikidata":"https://www.wikidata.org/wiki/Q83353","display_name":"Mineralogy","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:www.duo.uio.no:10852/63520","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-66073","pdf_url":"http://urn.nb.no/URN:NBN:no-66073","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},{"id":"mag:2980665336","doi":null,"is_oa":false,"landing_page_url":"https://www.duo.uio.no/handle/10852/63520","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:www.duo.uio.no:10852/63520","doi":null,"is_oa":true,"landing_page_url":"http://urn.nb.no/URN:NBN:no-66073","pdf_url":"http://urn.nb.no/URN:NBN:no-66073","source":{"id":"https://openalex.org/S7407064446","display_name":"NORA - Norwegian Open Research Archives","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2980665336.pdf","grobid_xml":"https://content.openalex.org/works/W2980665336.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2750215871","https://openalex.org/W4245822607","https://openalex.org/W2883209686","https://openalex.org/W2611078024","https://openalex.org/W2346788807","https://openalex.org/W2884835913","https://openalex.org/W2905936571","https://openalex.org/W2921909972","https://openalex.org/W2940695156","https://openalex.org/W2983783768"],"abstract_inverted_index":{"Introduksjon":[0],"Utvikling":[1],"av":[2,28,34,43,108,238,244,259,389,538,559,652,660],"post-transplantasjonsdiabetes":[3],"mellitus":[4],"(PTDM)":[5],"hos":[6,75,99,375,391,406,424],"nyretransplanterte":[7,29,100,124,392,425],"pasienter":[8,30,77,101,125,359,393,426,539,560],"er":[9,45,115,187,211,380,409],"en":[10,106,116,163,260],"alvorlig":[11],"komplikasjon":[12],"assosiert":[13],"med":[14,78,86,102,127,143,176,192,207,305,394,427,464,536,557,576],"\u00f8kt":[15],"risiko":[16],"for":[17,48,273,451,477,486,504,516,523,533,546,554,564,573,590,596,601,610,630,648,658,669,675],"kardiovaskul\u00e6r":[18,64,84],"sykdom":[19],"og":[20,41,65,82,95,111,142,218,228,234,256,266,290,329,345,365,369,387,439,447,459,462,493,508,522,525,542,545,563,581,595,608,616,628,633,667,679],"tidlig":[21],"d\u00f8d.I":[22],"Norge":[23],"utvikler":[24],"10":[25,159],"-13":[26],"%":[27],"PTDM":[31,44,103,128],"i":[32,68,129,166,173,185,189,213,247,253,295,321,343,367,650],"l\u00f8pet":[33],"de":[35,602],"f\u00f8rste":[36,382],"ti":[37],"ukene":[38],"etter":[39,150,307,336],"transplantasjon.Forebygging":[40],"behandling":[42],"derfor":[46],"viktig":[47],"\u00e5":[49,61,71,90,351,487],"bedre":[50],"langtidsutsiktene":[51],"til":[52,70,131,156,168,203,264,268,540,561,636,656],"denne":[53,87,277,296,407],"pasientgruppen.Natrium":[54],"glukose":[55,135],"co-transport\u00f8r":[56],"2":[57,81,181,358],"(SGLT2)hemmere":[58],"har":[59,348,397,436,443,457,640],"vist":[60,350,398],"redusere":[62,352],"b\u00e5de":[63,322],"total":[66],"d\u00f8delighet":[67],"tillegg":[69,167,347],"gi":[72],"nyrebeskyttende":[73],"effekt":[74,386],"ikke-transplanterte":[76],"diabetes":[79],"type":[80],"etablert":[83],"sykdom.Hensikten":[85],"oppgaven":[88],"var":[89,270,298,340,355,494,520],"unders\u00f8ke":[91],"om":[92,418],"empagliflozin":[93,158,289,300,349,390,400,420],"sikkert":[94],"effektivt":[96],"bedrer":[97],"glukosemetabolismen":[98],"unders\u00f8kt":[104],"ved":[105,231],"interimanalyse":[107],"EMPA-RenalTx":[109,113,248,378,413],"studien.Materiale":[110],"metode":[112],"studien":[114,186,379,383,414,541,562,618],"p\u00e5g\u00e5ende":[117],"utpr\u00f8ver-initiert,":[118],"placebo-kontrollert,":[119],"dobbelt-blindet,":[120],"randomisert":[121],"studie.Totalt":[122],"50":[123],"diagnostisert":[126],"henhold":[130],"WHO":[132],"definisjonen":[133],"(fastende":[134],"\u22657,0":[136],"mmol/L":[137],"og/eller":[138],"2-timersglukose":[139],"\u226511,1":[140],"mmol/L)":[141],"stabil":[144],"nyrefunksjon":[145],"inkluderes":[146],">":[147],"1":[148],"\u00e5r":[149],"transplantasjon.De":[151],"inkluderte":[152],"pasientene":[153,245,250,613],"randomiseres":[154],"1:1":[155],"enten":[157],"mg":[160],"eller":[161,501],"placebo":[162,306],"gang":[164],"daglig,":[165],"eventuelt":[169,421],"andre":[170],"antidiabetiske":[171],"legemidler,":[172],"24":[174,205,308,337],"uker.Pasienter":[175],"estimert":[177],"GFR":[178],"<30":[179],"mL/min/1,73m":[180],"ekskluderes.Det":[182],"prim\u00e6re":[183],"endepunktet":[184],"endring":[188,212],"gjennomsnittsglukose":[190],"(m\u00e5lt":[191],"kontinuerlig":[193],"glukosemonitorering":[194],"over":[195],"3":[196],"d\u00f8gn,":[197],"iPro":[198],"TM":[199],"2)":[200],"fra":[201,412],"baseline":[202],"uke":[204],"sammenlignet":[206,304],"placebo.De":[208],"sekund\u00e6re":[209],"endepunktene":[210],"HbA1c,":[214],"fastende":[215],"plasmaglukose":[216],"(FPG)":[217],"plasmainsulin,":[219],"insulinsekresjonsindeks,":[220],"kroppsvekt,":[221],"BMI,":[222],"midje/hofte-ratio,":[223],"blodtrykk,":[224],"karstivhet,":[225],"visceralt":[226],"fett":[227],"urinsyre.Sikkerheten":[229],"kontrolleres":[230],"glukosemonitorering,":[232],"urinpr\u00f8ver":[233],"blodpr\u00f8ver":[235],"(inkludert":[236],"blodkonsentrasjoner":[237],"immunsuppressiva).Denne":[239],"interimanalysen":[240,278,297,396],"omfatter":[241],"totalt":[242],"40":[243],"inkludert":[246],"studien.Disse":[249],"ble":[251,279,311,317,371],"fordelt":[252],"gruppe":[254,257,286,291],"A":[255,287],"B":[258,292],"person":[261],"uten":[262,686],"tilknytning":[263],"studien,":[265],"identiteten":[267],"gruppene":[269],"ukjent,":[271],"ogs\u00e5":[272],"masterstudenten.VI":[274],"Resultater":[275],"I":[276],"det,":[280],"ut":[281],"ifra":[282],"resultatene,":[283],"antatt":[284],"at":[285,299,399,478,517,670],"fikk":[288,293],"placebo.Hovedfunnet":[294],"bedret":[301],"glukosemetabolisme":[302],"signifikant":[303,313,319,341],"ukers":[309],"behandling.Gjennomsnittsglukose":[310],"ikke":[312,683],"redusert,":[314],"men":[315],"det":[316,356,370],"observert":[318,372],"reduksjon":[320,342],"HbA1c":[323],"(6,5":[324],"prosentpoeng,":[325,332],"p-verdi":[326],"=":[327,334],"0,0013)":[328],"FPG":[330],"(18,9":[331],"pverdi":[333],"0,014)":[335],"uker.Andre":[338],"funn":[339],"kroppsvekt":[344],"BMI.I":[346],"urinsyre.Under":[353],"studieperioden":[354],"kun":[357],"som":[360,384,415,456,614,624,639],"opplevde":[361],"bivirkninger":[362],"(UVI,":[363],"soppinfeksjon":[364],"hevelse":[366],"ansiktet),":[368],"moderat":[373],"hypoglykemi":[374],"7":[376],"pasienter.Konklusjon":[377],"den":[381],"unders\u00f8ker":[385],"sikkerhet":[388],"PTDM.Denne":[395],"kan":[401,416,422],"v\u00e6re":[402],"et":[403],"godt":[404,482],"behandlingsalternativ":[405],"pasientgruppen.Det":[408],"imidlertid":[410],"sluttresultater":[411],"konkludere":[417],"hvorvidt":[419],"brukes":[423],"PTDM.VII":[428],"Forord":[429],"\u00c5ret":[430],"p\u00e5":[431,511,593,621],"Nyrefysiologisk":[432],"Laboratorium,":[433],"OUS":[434],"Rikshospitalet,":[435],"v\u00e6rt":[437,684],"fantastisk":[438],"spennende,":[440],"hvor":[441],"jeg":[442,498,664],"l\u00e6rt":[444],"masse":[445],"nytt":[446],"f\u00e5tt":[448],"gode":[449,634,637],"minner":[450],"livet.Jeg":[452],"vil":[453,663],"takke":[454,665],"alle":[455,505],"hjulpet":[458],"st\u00f8ttet":[460,641],"meg":[461,481,489,642,678],"bidratt":[463],"masteroppgaven.En":[465],"ekstra":[466],"stor":[467],"takk":[468,609,655],"til:":[469],"MSc.Pharm,":[470],"post":[471,569],"doc":[472,570],"Thea":[473],"Anine":[474],"Str\u00f8m":[475],"Halden":[476],"du":[479,518],"tok":[480],"imot.Du":[483],"brukte":[484],"tid":[485],"veilede":[488],"gjennom":[490,643],"dette":[491],"\u00e5ret":[492],"alltid":[495,519,672],"tilgjengelig":[496,521],"da":[497],"trengte":[499],"hjelp":[500,526,535,548,556,566,575,598],"hadde":[502,606],"sp\u00f8rsm\u00e5l.Takk":[503],"l\u00e6rerike":[506],"dager":[507,592],"fine":[509,611],"samtaler":[510],"laben.Professor":[512],"dr.scient":[513],"Anders":[514],"\u00c5sberg":[515],"veiledning":[524],"under":[527,543,549,567,599],"skriveprosessen.Overlege":[528,550],"professor":[529],"dr.med":[530,551],"Trond":[531],"Jenssen":[532],"all":[534,547,555,565,574,597],"inkludering":[537,558],"studievisittene":[544],"Karsten":[552],"Midtvedt":[553],"studievisittene.MSc.Pharm,":[568],"Elisabet":[571],"St\u00f8rset":[572],"R.":[577,588],"Sykepleierne":[578],"Sebastian":[579],"M\u00fcller":[580],"Helga":[582],"G.":[583],"S\u00f8rh\u00f8y,":[584],"samt":[585],"bioingeni\u00f8ren":[586],"Hanne":[587],"Moldskred":[589],"fantastiske":[591],"laben":[594],"studiedagene.Takk":[600],"koselige":[603],"lunsjene":[604],"vi":[605],"sammen":[607],"samtaler.Alle":[612],"deltok":[615],"gjorde":[617,625],"mulig.Mine":[619],"medstudenter":[620],"Gydas":[622],"vei":[623],"skriveprosessen":[626],"enklere,":[627],"Iram":[629],"veiledning,":[631],"st\u00f8tte":[632],"masterdiskusjoner.Takk":[635],"venner":[638],"hele":[644],"\u00e5ret,":[645],"spesielt":[646],"Lambert-gjengen":[647],"motivasjonen":[649],"sluttspurten":[651],"skriveprosessen.En":[653],"spesiell":[654],"Saraingiy":[657],"korrekturlesing":[659],"oppgaven.Til":[661],"slutt":[662],"mamma":[666],"pappa":[668],"dere":[671],"stiller":[673],"opp":[674],"meg,":[676],"st\u00f8tter":[677],"motiverer":[680],"meg.Dette":[681],"ville":[682],"mulig":[685],"dere.":[687]},"counts_by_year":[],"updated_date":"2026-09-03T10:48:47.769340","created_date":"2019-10-25T00:00:00"}